How did Tempus AI's revenue and expenses trend in Q4 2024 compared to previous quarters?

**Tempus AI's revenue showed a consistent upward trend from Q1 to Q4 2024**, with significant growth in Q3 and Q4. Here's a detailed analysis:

1. **Revenue Trend**:
- Q4 2024: Total revenue was $693.4 million.
- Q3 2024: Total revenue was $640.44 million.
- Q2 2024: Total revenue was $562.02 million.
- Q1 2024: Total revenue was $531.82 million.
- Clearly, there was a seasonal increase from Q3 to Q4, and a strong upward trajectory from Q1 to Q3.

2. **Expense Trend**: There are no available data on Tempus AI's expenses for Q4 2024 and earlier quarters. However, the information on Q1 2025 earnings report suggests that the company's costs were "remaining in check" which allowed for significant year-over-year operating leverage. This implies that while revenue was growing, the company was able to manage costs effectively, resulting in improved margins.
3. **Key Drivers of Growth**: The growth in revenue can be attributed to strategic investments in AI and data services. For instance, the genomics segment saw a 88.9% year-over-year growth, contributing $193.8 million in revenue. Data and services also grew by 43.2% to $61.9 million, led by Insights (data licensing), which grew 58% year-over-year. Additionally, the company's collaborations with AstraZeneca and Pathos are expected to generate additional revenue.
4. **Financial Outlook**: Tempus AI raised its full-year 2025 revenue guidance to $1.25 billion, representing approximately 80% growth year-over-year. The company expects to achieve positive adjusted EBITDA of $5 million for the full year, an improvement of about $110 million over 2024.

In conclusion, Tempus AI has demonstrated strong revenue growth and effective cost management, which has led to improved financial leverage and a positive outlook for the future.